The identification of stimulatory factors for hematopoiesic cells has greatly enhanced our understanding of the regulation of hematopoiesis (1, 2) . While these factors augment cellular proliferation and differentiation, less is known about those factors that might be involved in either negative growth regulation or the regulation of homeostasis of hematopoiesis. A new family of polypeptide growth factors that regulate cell growth and differentiation has recently been identified which includes transforming growth factor type R (TGF R),' inhibin, Mfillerian inhibitory substance, and decapentaplegic gene complex (3) . TGF R activity was originally identified in the supernatants of transformed fibroblasts by its ability to induce the anchorageindependent growth (transformed phenotype) of NRK 49F fibroblasts in soft agar (4, 5) . TGF-(3 was initially purified to homogeneity from human platelets (6) and was subsequently found to be produced by many normal tissues (7) . TGF-0 is a 25-kD disulfide-linked homodimeric protein whose sequence is highly conserved, with a single amino acid difference between mouse and man (8) . Recently, a second form of TGF p was identified in bovine bone called CIF-13 (9) , now known as TGF (i2, that shares significant homology to the first type of TGF (3, now known as TGF (31 (10) . TGF-R1 has been shown to be multifunctional in its influence on cellular proliferation by also acting as a growth inhibitor ofmany different cell types including hepatocytes, keratinocytes and embryo fibroblasts (7, 11) . the spleen focus forming virus (SFFV) were obtained as previously described (25) . Cells were cultured in the presence or absence of Epo at 37°C at a concentration of 4 x 106 cells/ml in 0.1 ml of RPMI 1640, 10% FCS, 0.1 mM 2-ME for 24 h with a 2-h pulse of [3H]TdR, and they were harvested as described above for the bone marrow.
Soft Agar Colony Formation. A modification of the method of Stanley et al. (26) was used to measure colony formation of bone marrow cells . Briefly, BALB/c bone marrow cells were suspended in 1 ml RPMI 1640, 10% FCS, 0.1 mM 2-ME in 0.3% Seaplaque agarose (Rockland, ME) with a source of CSF and incubated in 35-mm Lux petri dishes (Miles Laboratories Inc., Naperville, IL) at 37°C in 5% C02 and scored for colony growth (CFU) at the indicated times. For GM colony numbers, all colonies >50 cells are counted . For the growth of multipotential colonies, granulocyte, erythroid, megakaryocyte, and macrophage (CFU-GEMM), cultures were additionally supplemented with hemin and Epo. In the CFU-GEMM assay, only the colonies that contain all four lineages are counted, even though other colonies are present. For the formation of erythroid colonies, CFU-E, cells were cultured for 2 d in a plasma clot system (27) in the presence of 0.5 U/ml Epo and the clots were stained with benzidine and examined microscopically for benzidine-positive colonies .
Results
Effect of TGF--/31 on Factor-induced Murine Bone Marrow Proliferation. Normal bone marrow cells are known to proliferate in the presence of a number ofgrowth factors. IL-3 promotes the differentiation of multipotent stem cells as well as more lineagerestricted hematopoietic progenitors, while other growth factors such as G-CSF, GM-CSF, and Epo are known to act upon cells later in the various hematopoietic lineages and exhibit relatively restricted lineage specificity (1, 2) . To test the effects of TGF (31 on the proliferation of bone marrow cells in the presence of various factors, freshly aspirated cells were used in a standard proliferation assay. As shown in Fig . 1 , II:-3-driven proliferation of bone marrow cells was inhibited by TGF01 in a closedependent manner with an ED-50 of 0.05 ng/ml (2 pM) . The same effect was observed whether the assay was performed with a low dose of IL-3 (5 U/ml) or saturating amounts of IL-3 (50 U/ml) . Kinetic experiments demonstrated that maximum inhibition was observed after the cells had been incubated for 48 h with TGFR1 . The antiproliferative effects were not due to cytotoxicity since TGF-(31 did not affect the viability of cultured bone marrow cells (data not shown) .
In contrast, TGF01 showed no effects on G-CSF or GM-CSFdriven proliferation in the presence of increasing concentrations of TGF [31 ( Fig. 1) . Thus, TGF(31 showed a differential effect on CSFinduced normal bone marrow proliferation . In addition, not all of the bone marrow proliferation stimulated by IL-3 is inhibitable by TGFR1 .
Effect of TGF-,Q1 on Murine Hematoiboietic Colony Formation. Under conditions of limiting cell number, soft agar assays provide a convenient means to measure the clonal proliferation as well as the differentiation potential of hemaotpoietic progenitors . Therefore, soft agar colony assays were used to determine the extent of TGFD1 inhibition within particular cell lineages. TGFDl suppressed IL-3-induced CFU-GM colony formation using 10 ng/ml TGFR1, a concentration that maximally inhibited [3H]TdR incorporation in the bone marrow proliferation assay (Table I) . While overall colony formation was consistently inhibited by TGFD, small clusters (<20 cells) and a few colonies were also consistently observed . This effect was observed when 5 U/ml or 50 U/ml of IL-3 was used. TGF(31 inhibition of IL-3-induced CFU-GM colonies occurred in a dose-dependent manner with an ED-50 of5-10 pM (Fig. 2) . In agreement with proliferation data, TGF(31 had no inhibitory effect on G-CSF or GM-CSFpromoted hematopoietic cell colony formation, although an increased colony number was obtained in some experiments with GM-CSF (Table I) . When adherent bone marrow cells were removed by absorbance to plastic petri dishes before plating in the assay, increased colony formation observed with GM-CSF was decreased (data not shown) . Thus, TGFR1 differentially regulates colony formation in that it is a potent inhibitor ofIL-3-induced colony formation but not ofGM-CSF or G-CSFpromoted colony formation.
Effect of TGF-01 on Multipotential Colony Formation. IL-3 promotes the proliferation and differentiation in soft agar ofmany hematopoietic lineages from bone marrow and in the presence of Epo can induce the proliferation and differentiation of one of the earliest in vitro colonies, CFU-GEMM, a colony consisting of four hematopoietic lineages (1, 2) . Colony assays to measure CFU-GEMM formation were set up to determine if TGF-01 had an effect on the formation of these earliest hematopoietic colonies . In the absence of TGFp1, between five and eight CFU-GEMM colonies were scored in three separate experiments, while in the presence ofTGF-01 no CFU-GEMM colonies were detected (Table II) . This result is also depicted in the transmission photomicrograph in Fig.3 , where in the absence of TGF01 (panel A) a multilineage colony with cell types from the four lineages is observed, while in the presence of TGF0l only small clusters of differentiated granulocytes or macrophages were obtained . Therefore, TGF-01 blocks the proliferation and differentiation of early hematopoietic progenitors (CFU-GEMM) while allowing clusters (<20 cells) of more differentiated progeny to develop, which explains why IL-3-induced bone marrow proliferation is not completely inhibited by TGF(31. Epo (2 U/ml) -0 IL-3 (50 U/ml) + Epo (2 U/ml) -5-8 IL-3 (50 U/ml) + Epo (2 U/ml) + 0
Cultures were grown in the presence ( + ) or absence ( -) of 1 ng/ml TGF-pl . 1 Colony formation was scored after 10 d . These data are representative of three separate experiments .
Effect of TGF-01 on Erythroid Development . Two factors are needed to promote the growth of erythroid development in CFU-GEMM colonies, namely IL-3, which affects the growth and differentiation of early progenitor cells, and Epo, which stimulates the proliferation and terminal differentiation of late erythroid progenitors. Since the data on CFU-GEMM formation indicated that TGFpl could inhibit the proliferation and differentiation of early erythroid progenitor cells, we were interested in whether or not it would also inhibit the Epo-driven later stages of erythroid cell growth . As shown in Fig. 4 , Epo promotes the proliferation of spleen cells from phenylhydrazine-treated mice (90% are erythroid precursors) in a dose-dependent manner. In the presence of saturating amounts of Epo, TGF(31 had no inhibitory effect when tested over a wide range of concentrations . In addition, TGF-01 had no effect on Epo-induced late erythroid colony formation (CFU-E) (Table III) . Therefore, TGF-01 appears to suppress the proliferation and differentiation of early uncommitted hematopoietic progenitor cells but is inactive on later precursor cells that are committed to a particular lineage.
Effect of TGF-01 on Factor-dependent and -independent Myeloid Leukemic Cell Lines. Since the data suggest that TGFR1 might play a role in regulating the growth and differentiation of early but not late hematopoietic progenitor populations, we examined a variety of factor-dependent progenitor cell lines representing leukemic clonal populations or early myeloid cells blocked in early stages of differentiation based on their phenotype, function, and morphology (22) . As shown in Fig. 5 , TGFQ1 inhibits IL-3-induced proliferation of the NFS-60 cell line using either 0.5 U/ml or 50 U/ml of IL-3 . Data from several experiments demonstrate that the inhibition is dosedependent with an ED-50 of 5-15 pM . Using a polyclonal antiserum to TGF-(31, the inhibitory effects of TGF-01 on IL-3-driven proliferation were effectively neutralized in a dose-dependent manner, while normal rabbit serum showed no effect (Fig. 6) , demonstrating the action of TGF-01 could be specifically neutralized . In addition, GM-CSFinduced and G-CSFinduced proliferation of NFS-60 cells is also inhibited by TGFPI in a dose-dependent manner (panels B and C) with ED-50s of 5-15 pM . NFS-60 cells also provide a convenient means to test two other growth factors, CSF1 and BSF-1/IL-4 . As shown in Fig. 7 , the proliferation of NFS-60 cells in the presence of saturating amounts of each factor was inhibited by TGFR1 in dose-dependent manner with ED-50s of 5-10 pM for CSF1 and IL-4 .
Inhibition of proliferation in the presence of TGF-01 was consistently observed among other factor dependent cell lines regardless of their derivation with similar results (Table IV) . In addition to the factor-dependent cell lines, a factor-independent myelomonocytic cell line, WEHI-3B, was also inhibited in a dose-dependent manner by TGF-(31 . TGF (31 did not induce the differentiation of those lines that were inhibited . In contrast, growth of factor independent cell lines of erythroid, macrophage and mast cell lineages, blocked late in their respective lineages, were not inhibited by TGF-R1 . 
Discussion
The production ofblood cells is regulated by cells which produce stimulatory and inhibitory molecules, as well as those cells that can respond to these factors (1, 2). Evidence presented here suggests that TGFal may serve a critical regulatory role in murine hematopoiesis in that it is a potent negative regulator of early but not late hematopoietic growth and differentiation . Specifically, TGF R1 inhibits early IL-3-induced bone marrow progenitor cell proliferation and colony growth in soft agar, but has no suppressive influence on the proliferation and differentiation induced by other later acting hematopoietic growth factors, G-CSF, GM-CSF, and Epo . In addition, while colony formation is significantly inhibited in cultures containing IL-3 and TGF-(31, clusters and small colonies of differentiated myeloid cells of one lineage were consistently seen . This is consistent with bone marrow proliferation data that show some IL-3-induced proliferation occurs in the presence of TGF (31. Also, TGF(31 selectively blocks the growth and differentiation of early multipotential progenitor cells (IL-3-regulated CFU-GEMM), a component of which is representative of early erythroid differentiation, while it has no effect on the late stages oferythroid differentiation (Epo-regulated CFU-E). Thus, the inhibitory effect of TGF-(31 on hematopoietic cells appears to be a function of the state of cellular differentiation, Erythroid colonies were scored after 48 h according to the assay described in the procedures . 1 Cultures were supplemented with 1 ng/ml TGF-01 . § Normal, phenylhydrazine-treated, and Friend virus-infected splenocytes were obtained as described in the Materials and Methods . These data are representative of three separate experiments . such that, as erythroid and myeloid cells undergo maturation there is a point at which they become insensitive to the inhibitory effect of TGF (31 . The resistance to the inhibitory action of TGF (i1 could be a result of a change in the affinity or number of TGF01 receptors . Therefore, experiments have been initiated to determine both the biological effect as well as the receptor status on purified populations of more differentiated hematopoietic progenitors . While the soft agar colony assay measures the clonal growth and differentiation of hematopoietic progenitors, it is not possible under these circumstances to rule out that the action of an exogenous factor might be due to the indirect effects on other subpopulations . However, since receptors for TGF-01 are present on all cell types (7), to conclusively prove that TGF-a1 is acting directly, one would need a pure population of progenitor cells. A reasonable approach would be to examine clonal hematopoietic growth factor cell lines. The results with NSF-60 cells, which are clonal as demonstrated by the presence of a rearranged c-myb locus in all cells (28) , suggests that TGF-(31 can act directly on hematopoietic cell progenitors . Dose response of TGF-01 on CSF-1 and IL-4-induced proliferation of NFS-60 cells. NFS-60 cells were plated into microtiter wells at a density of 105/ml and harvested according to procedures in the Materials and Methods. CSF-1 (A) and IL-4 (C) were diluted at the indicated concentrations into culture medium, or TGF01 was diluted at the indicated concentrations into medium containing a constant amount of CSF-1, 20 U/ml (B), and IL-4 200 U/ml (D). Arrows indicate CSF-1-and IL-4-induced proliferation in the absence TGF-01 or background proliferation (BKG).
TABLE IV
Efect of TGF-01 on Leukemic Cell Lines " Cell proliferation assays were performed according to the procedures in the Materials and Methods. TGF-pl was diluted into cell proliferation assays to generate a dose response curve starting at a concentration of 40 ng/ml. The range represents the maximum percent inhibition obtained from the dose-response curves from three separate experiments .
Nonetheless, experiments have been designed to support the direct action of TGF (31 by testing IL-3-induced Thy-1 + murine progenitors obtained by FAGS (29) .
Since both murine and human leukemic cells have been shown to maintain growth factor responsiveness in vitro, a loss of negative growth control might contribute to a preleukemic state by permitting the unrestrained growth of factor-dependent leukemic clones . Such a process might result, for example, in the out-growth of IL-3-dependent myeloid leukemic progenitor cells . Our results indicate, however, that the growth of IL-3-dependent leukemias in vitro is inhibited by TGF-01 and that this effect is seen regardless of the growth factor used to signal proliferation . It is possible that additional events (abrogation of factor dependence) may be required to escape negative regulation . Alternatively, others (7, 11, 30, 31) found that the human melanoma cell line A549 produces an inactive or latent form of TGFR1, while it is potently inhibited by exogenous TGF (31, thus leading to the proposal that a lesion in TGF-(31 activation might have contributed to the evolution of this cancer. Our laboratory has recently found that while IL-3-dependent myeloid leukemic cells express messenger RNA for TGF-01 (manuscript in preparation), no TGF-P1 bioactivity in the supernatant has been detected. Thus, experiments are underway to determine if the TGF-01 protein is produced and whether it is secreted in a latent or inactive form which might result in the breakdown of negative autocrine growth control .
In summary, TGF R 1 may serve a critical regulatory role in murine hematopoiesis in that it is a potent negative regulator ofearly but not late hematopoietic differentiation and proliferation . Thus, in normal cell populations, TGF-(31 is a differential regulator of growth factor-promoted hematopoietic differentiation . In addition, TGF (31 inhibits the growth of differentiated-arrested factor-dependent and -independent leukemic myelomonocytic cells but not those leukemias blocked late in their lineage .
The capacity to selectively inhibit early marrow cell and leukemic cell prolifera- (31) has been shown to be associated with active centers of hematopoiesis and lymphopoiesis in the developing fetus. Therefore, the effects of TGF Q1 on mouse hematopoiesis were studied . TGF~l is a potent inhibitor of IL-3-induced bone marrow proliferation, but it does not inhibit the proliferation induced by granulocyte/macrophage, colony-stimulating factor (CSF), granulocyte CSF, and erythropoietin (Epo). TGF 0l also inhibits IL-3-induced multipotential colony formation of bone marrow cells in soft agar, which includes early erythroid differentiation, while Epo-induced terminal differentiation is unaffected . In addition, IL-3-induced granulocyte/macrophage colonies were inhibited ; however, small clusters of differentiated myeloid cells were consistently seen in cultures containing IL-3 and TGF (31. Thus, TGF-al selectively inhibits early hematopoietic progenitor growth and differentiation but not more mature progenitors . TGF-(31 is also a potent inhibitor of IL-3-dependent and -independent myelomonocytic leukemic cell growth, while the more mature erythroid and macrophage leukemias are insensitive . Therefore, TGF (31 functions as a selective regulator of differentiating normal hematopoietic cells, and suppresses myeloid leukemic cell growth.
